Related Experiment Video

Updated: Aug 16, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Nanovesicular vaccines: exosomes

Xiaobo Li1, Zhiren Zhang, Thomas Beiter

  • 1Institute of Brain Research, D-72076 Tuebingen, Germany. lixiaobo1007@hotmail.com

Archivum Immunologiae Et Therapiae Experimentalis
|August 10, 2005
PubMed

Insights

Exosomes, small vesicles involved in cell communication, are being explored as potential anti-tumor vaccines. These extracellular vesicles show promise in fighting cancer and are currently in clinical trials.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Exosomes are nanoscale extracellular vesicles originating from multivesicular bodies.
  • They mediate intercellular communication by transferring proteins and RNA between cells.
  • All cells with endocytic pathways can potentially secrete exosomes.

Purpose of the Study:

  • To investigate the role of exosomes in intercellular communication.
  • To explore the potential of exosomes as anti-tumor agents and vaccines.
  • To review the current understanding of exosome biology and therapeutic applications.

Main Methods:

  • Analysis of exosome biogenesis and secretion pathways.
  • Investigation of exosome content, including membrane and cytoplasmic proteins.
  • Evaluation of immunorelevant structures carried by exosomes (MHC, costimulatory molecules, tumor antigens).

Main Results:

  • Exosomes facilitate the removal of obsolete proteins and act as intercellular messengers.
  • Tumor-derived exosomes carry antigens and immune-modulating molecules.
  • Exosomes have demonstrated significant anti-tumor effects in preclinical studies.

Conclusions:

  • Exosomes play crucial roles in cell-to-cell communication and immune responses.
  • Exosomes derived from tumor cells hold potential as cancer vaccines.
  • Exosome-based cancer therapies are progressing to clinical trials.

More Related Videos

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions09:36

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
COP Coated Vesicles00:59

COP Coated Vesicles

Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell eating"). Pinocytosis is...
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...